Author

Ezgi Dayar

Observed name: E. Dayar

Institutions: Slovak Academy of Sciences, Centre of Experimental Medicine of the Slovak Academy of Sciences, Institute of Normal and Pathological Physiology of the Slovak Academy of Sciences

Observed institutions: Dokuz Eylül University, Slovak Academy of Sciences, Centre of Experimental Medicine of the Slovak Academy of Sciences, Institute of Normal and Pathological Physiology of the Slovak Academy of Sciences

ORCID: 0000-0001-5567-1408

Observed ORCID: 0000-0001-5567-1408

OpenAlex ID: A5086763897

Targeted Strategy in Lipid-Lowering Therapy

2022 · Ezgi Dayar, Olga Pechanova · Biomedicines · 59

Therapeutic Potential of Polyphenols-Loaded Polymeric Nanoparticles in Cardiovascular System

2020 · Olga Pechanova, Ezgi Dayar, et al. · Molecules · 59

Antioxidant Effect of Lonicera caerulea L. in the Cardiovascular System of Obese Zucker Rats

2021 · Ezgi Dayar, Martina Cebova, et al. · Antioxidants · 21

Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760—Benefit or Detriment in Essential Hypertension?

2021 · Andrea Berenyiova, Iveta Bernatova, et al. · Biomedicines · 20

Do penile haemodynamics change in the presence of hydrogen sulphide (H2S) donor in metabolic syndrome-induced erectile dysfunction?

2017 · E. Dayar, E. Kara, et al. · Andrologia · 14

The role of resistin on metabolic syndrome‐induced erectile dysfunction and the possible therapeutic effect of Boldine

2020 · Erkan Kara, Erkan Kahraman, et al. · Andrology · 12

Beneficial Effects of Cornelian Cherries on Lipid Profile and NO/ROS Balance in Obese Zucker Rats: Comparison with CoQ10

2020 · Ezgi Dayar, Martina Cebova, et al. · Molecules · 11

Angiotensin System Modulations in Spontaneously Hypertensive Rats and Consequences on Erythrocyte Properties; Action of MLN-4760 and Zofenopril

2021 · Tomas Jasenovec, Dominika Radosinska, et al. · Biomedicines · 5

Works count: 8

Citation count: 201

H-index: 7

I10-index: 7